ThermoGenesis Holdings, Inc.
(NASDAQ : KOOL)

( )
KOOL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
-0.42%143.000.7%$487.17m
MDTMedtronic Plc
-0.22%111.520.6%$444.69m
TMOThermo Fisher Scientific, Inc.
0.29%307.321.0%$393.89m
ABTAbbott Laboratories
-0.48%83.890.8%$391.41m
BDXBecton, Dickinson & Co.
0.37%246.691.1%$342.17m
SYKStryker Corp.
-1.36%204.301.3%$338.26m
BAXBaxter International, Inc.
0.40%82.001.8%$325.55m
ISRGIntuitive Surgical, Inc.
-0.91%572.532.4%$311.93m
BSXBoston Scientific Corp.
-0.07%42.601.1%$293.44m
EWEdwards Lifesciences Corp.
0.27%244.211.2%$283.39m
DXCMDexCom, Inc.
1.72%221.338.3%$280.12m
WMGIWright Medical Group NV
-0.27%29.518.3%$265.97m
ALGNAlign Technology, Inc.
-1.04%268.776.4%$252.64m
ABMDABIOMED, Inc.
0.49%185.253.3%$167.50m
PODDInsulet Corp.
-0.37%180.236.7%$153.20m

Company Profile

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine. It operates through the following segments: Device and Clinical Development. The Device segment includes development and commercialization of automated systems that provide good manufacturing practice, clinical grade cell-banking, cell-processing and cell-based therapeutics. The Clinical Development segment develops autologous stem cell-based therapeutics that address significant unmet medical needs for the vascular, cardiology, and orthopedic markets. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.